Abstract
Esophageal motility disorders (EMD) can have significant effects on quality of life. Patient-reported outcomes (PROs) provide valuable insight into the patient’s perspective on their treatment and are becoming increasingly used in randomized controlled trials (RCTs). Thus, our investigation aims to evaluate the completeness of reporting of PROs in RCTs pertaining to EMDs. We searched MEDLINE, Embase, and Cochrane Central Register of Controlled Trials for published RCTs focused on EMDs. Included RCTs were published between 2006 and 2020, reported a primary outcome related to an EMDs, and listed at least one PRO measure as a primary or secondary outcome. Investigators screened and extracted data in a masked, duplicate fashion. Data extraction was carried out using both the CONSORT-PRO adaptation and Cochrane Collaboration Risk of Bias 2.0 tool. We assessed overall mean percent completion of the CONSORT-PRO adaptation and a bivariate regression analysis was used to assess relationships between trial characteristics and completeness of reporting. The overall mean percent completion of the CONSORT-PRO checklist adaptation was 43.86% (SD = 17.03). RCTs with a primary PRO had a mean completeness of 47.73% (SD = 17.32) and RCTs with a secondary PRO was 35.36% (SD = 13.52). RCTs with a conflict of interest statement were 18.15% (SE = 6.5) more complete (t = 2.79, P = .009) than trials lacking a statement. No additional significant associations between trial characteristics and completeness of reporting were found. PRO reporting completeness in RCTs focused on EMDs was inadequate. We urge EMD researchers to prioritize complete PRO reporting to foster patient-centered research for future RCTs on EMDs.
Similar content being viewed by others
References
Aithal GP, Nylander D, Dwarakanath AD, Tanner AR. Subclinical esophageal peristaltic dysfunction during the early phase following a stroke. Dig Dis Sci. 1999;44(2):274–8.
Kuribayashi Y, et al. Esophageal motility after extensive circumferential endoscopic submucosal dissection for superficial esophageal cancer. Digestion. 2018;98(3):153–60.
Goyal M, Nagalli S. Esophageal motility disorders in StatPearls. Treasure Island (FL): StatPearls Publishing; 2021.
Rommel N, Hamdy S. Oropharyngeal dysphagia: manifestations and diagnosis. Nat Rev Gastroenterol Hepatol. 2016;13(1):49–59.
Gustafsson B, Tibbling L. Dysphagia, an unrecognized handicap. Dysphagia. 1991;6(4):193–9.
McGinnis CM, et al. Dysphagia: interprofessional management, impact, and patient-centered care. Nutr Clin Pract. 2019;34(1):80–95.
Ekberg O, Hamdy S, Woisard V, Wuttge-Hannig A, Ortega P. Social and psychological burden of dysphagia: its impact on diagnosis and treatment. Dysphagia. 2002;17(2):139–46.
American Speech-Language-Hearing Association. https://www.asha.org/. Accessed 29 Jun 2021.
Cui Y, Xia L, Li L, Zhao Q, Chen S, Gu Z. Anxiety and depression in primary Sjögren’s syndrome: a cross-sectional study. BMC Psychiatry. 2018;18(1):131.
Eslick GD, Talley NJ. Dysphagia: epidemiology, risk factors and impact on quality of life—a population-based study. Aliment Pharmacol Ther. 2008;27(10):971–9.
Anker SD, et al. The importance of patient-reported outcomes: a call for their comprehensive integration in cardiovascular clinical trials. Eur Heart J. 2014;35(30):2001–9.
Kluetz PG, Chingos DT, Basch EM, Mitchell SA. Patient-reported outcomes in cancer clinical trials: measuring symptomatic adverse events with the national cancer institute’s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). Am Soc Clin Oncol Educ Book. 2016;35:67–73.
Izadi Z, Gandrup J, Katz PP, Yazdany J. Patient-reported outcome measures for use in clinical trials of SLE: a review. Lupus Sci Med. 2018;5(1):e000279.
Franco P, et al. Prospective assessment of oral mucositis and its impact on quality of life and patient-reported outcomes during radiotherapy for head and neck cancer. Med Oncol. 2017;34(5):81.
Consort - Patient-Reported Outcomes (CONSORT PRO). http://www.consort-statement.org/extensions?ContentWidgetId=560. Accessed 28 Jun 2021.
Murad MH, Wang Z. Guidelines for reporting meta-epidemiological methodology research. Evid Based Med. 2017;22(4):139–42.
Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins GS, editor. Cochrane handbook for systematic reviews of interventions version 5.1.0. London: The Cochrane Collaboration; 2011.
C. Hillman, et al. Esophageal motility disorders. https://osf.io/mjgvp/. Accessed 21 Jul 2021
Kahrilas PJ, et al. The chicago classification of esophageal motility disorders, v3.0. Neurogastroenterol Motil. 2015;27(2):160–74.
Mercieca-Bebber R, et al. Preliminary evidence on the uptake, use and benefits of the CONSORT-PRO extension. Qual Life Res. 2017;26(6):1427–37.
Calvert M, et al. Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension. JAMA. 2013;309(8):814–22.
Cochrane Training. Part 1: an overview of how bias can arise during the randomization process. https://www.youtube.com/watch?v=tsfelr6JsY4. Accessed 25 Jul 2021.
Cochrane Training. https://www.youtube.com/channel/UCoWzvKR8RPHG07PPeqBiibA. Accessed 17 Jul 2021.
Risk of bias tools—current version of RoB 2. https://sites.google.com/site/riskofbiastool/welcome/rob-2-0-tool/current-version-of-rob-2?authuser=0. Accessed 21 Jul 2021.
Risk of bias tools—RoB 2 for crossover trials. https://sites.google.com/site/riskofbiastool/welcome/rob-2-0-tool/rob-2-for-crossover-trials?authuser=0. Accessed 21 Jul 2021.
Risk of bias tools—RoB 2 for cluster-randomized trials. https://sites.google.com/site/riskofbiastool/welcome/rob-2-0-tool/rob-2-for-cluster-randomized-trials?authuser=0. Accessed 21 Jul 2021.
Fielding S, Maclennan G, Cook JA, Ramsay CR. A review of RCTs in four medical journals to assess the use of imputation to overcome missing data in quality of life outcomes. Trials. 2008;9:51.
Karahalios A, Baglietto L, Carlin JB, English DR, Simpson JA. A review of the reporting and handling of missing data in cohort studies with repeated assessment of exposure measures. BMC Med Res Methodol. 2012;12:96.
Lee KJ, et al. Framework for the treatment and reporting of missing data in observational studies: the treatment and reporting of missing data in observational studies framework. J Clin Epidemiol. 2021;134:79–88.
Masconi KL, Matsha TE, Echouffo-Tcheugui JB, Erasmus RT, Kengne AP. Reporting and handling of missing data in predictive research for prevalent undiagnosed type 2 diabetes mellitus: a systematic review. EPMA J. 2015;6(1):7.
Fielding S, Ogbuagu A, Sivasubramaniam S, MacLennan G, Ramsay CR. Reporting and dealing with missing quality of life data in RCTs: has the picture changed in the last decade? Qual Life Res. 2016;25(12):2977–83.
Dziura JD, Post LA, Zhao Q, Fu Z, Peduzzi P. Strategies for dealing with missing data in clinical trials: from design to analysis. Yale J Biol Med. 2013;86(3):343–58.
Bell ML, Fiero M, Horton NJ, Hsu C-H. Handling missing data in RCTs; a review of the top medical journals. BMC Med Res Methodol. 2014;14:118.
Wayant C, Aran G, Johnson BS, Vassar M. Evaluation of selective outcome reporting bias in efficacy endpoints in print and television advertisements for oncology drugs. J Gen Intern Med. 2020;35(10):2853–7.
Wayant C, et al. Evidence of selective reporting bias in hematology journals: a systematic review. PLoS ONE. 2017;12(6):e0178379.
Saric F, Barcot O, Puljak L. Risk of bias assessments for selective reporting were inadequate in the majority of Cochrane reviews. J Clin Epidemiol. 2019;112:53–8.
Rankin J, Ross A, Baker J, O’Brien M, Scheckel C, Vassar M. Selective outcome reporting in obesity clinical trials: a cross-sectional review. Clin Obes. 2017;7(4):245–54.
He Z, et al. Clinical trial generalizability assessment in the big data era: a review. Clin Transl Sci. 2020;13(4):675–84.
Khorsan R, Crawford C. How to assess the external validity and model validity of therapeutic trials: a conceptual approach to systematic review methodology. Evid Based Complement Alternat Med. 2014;2014:694804.
Yorkston K, Baylor C. Patient-reported outcomes measures: an introduction for clinicians. Perspect ASHA Spec Interest Groups. 2019. https://doi.org/10.1044/2018_PERS-ST-2018-0001.
Acknowledgements
In memoriam of Abbey Renner, we are grateful for her expertise during the drafting of this manuscript. We are grateful to April Schweikhard who assisted in the development of our search strategy and to the OSU medical library for procurement of relevant literature.
Funding
Development of this study was funded by the Oklahoma State University Center for Health Sciences Presidential Mentor–Mentee Research Fellowship Grant.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
No financial or other sources of support were provided during the development of this manuscript. Dr. Hartwell reports receiving funding from the National Institute of Justice for work unrelated to the current subject. Dr. Vassar reports receipt of funding from the National Institute on Drug Abuse, the National Institute on Alcohol Abuse and Alcoholism, the US Office of Research Integrity, Oklahoma Center for Advancement of Science and Technology, and internal grants from Oklahoma State University Center for Health Sciences—all outside of the present work. All other authors have nothing to report.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Staggs, J., Williams, C., Love, M. et al. Evaluating Reporting Completeness of Patient-Reported Outcomes in Esophageal Motility Disorders: A Cross-Sectional Analysis of Randomized Controlled Trials. Dysphagia 37, 1576–1585 (2022). https://doi.org/10.1007/s00455-022-10415-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00455-022-10415-7